(Q43910524)

English

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

multiple sclerosis

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

Patzold T

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Schwengelbeck M

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ossege LM

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Malin JP

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sindern E

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Acta Neurologica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

164-168

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Clinical outcomes assessment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Intrarater and interrater reliability of the MS functional composite outcome measure.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

21 January 2018

The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The measurement of ambulatory impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paced auditory serial-addition task: a measure of recovery from concussion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

7 January 2021

based on heuristic

inferred from DOI database lookup

MS functional composite: relation to disease phenotype and disability strata

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O135.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0404.2002.1O135.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43910524&oldid=2104342897"